Nehal Chopra Ratan Capital Management
Nehal Chopra is the founder of Ratan Capital Management, a concentrated investment firm whose public portfolio is followed for high-conviction equity ideas. The firm’s filings often show a focused set of positions rather than a broad index-like book. Investors track Ratan as an example of a smaller, research-driven manager with differentiated stock selection.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$59.7M |
| 2 |
Post Holdings
POST
|
+$29.2M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$20.2M |
| 4 |
Bausch Health
BHC
|
+$12.1M |
| 5 |
Hilltop Holdings
HTH
|
+$5.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$32.1M |
| 2 |
Liberty Global Class A
LBTYA
|
+$21.3M |
| 3 |
Herbalife
HLF
|
+$19.1M |
| 4 |
FRX
FOREST LABORATORIES INC
FRX
|
+$18.6M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$10.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.19% |
| 2 | Consumer Staples | 18.18% |
| 3 | Industrials | 14.26% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Financials | 3.46% |
Similar funds
Nehal Chopra's Q1 2014 Portfolio in Review
As of Q1 2014, Nehal Chopra held 23 positions worth $410M, down 0.35% from $411M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Nehal Chopra withdrew a net $25.8M in Q1 2014, closing 8 positions and reducing 8 holdings. Its most notable exit was Allergan Inc, an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 39% a quarter earlier, followed by Consumer Staples and Industrials.
Against the trend, Nehal Chopra opened a new position in Allergan plc worth $62.1M.
- Nehal Chopra's largest Q1 2014 buy was Allergan plc: 301,495 shares worth $62.1M.
- Nehal Chopra added most to Post Holdings in Q1 2014, an estimated $29.2M increase.
- Nehal Chopra's biggest Q1 2014 reduction was FOREST LABORATORIES INC, cutting an estimated $18.6M.
- Nehal Chopra fully exited Allergan Inc in Q1 2014, selling an estimated $32.1M.
- Nehal Chopra's ten largest holdings make up 95% of its $410M portfolio in Q1 2014.
- Nehal Chopra opened 2 new positions and closed 8 in Q1 2014.
- Nehal Chopra's portfolio value fell 0.35% quarter-over-quarter to $410M.
Based on Ratan Capital Management's 13F filing for Q1 2014, filed 15 May 2014.